Last reviewed · How we verify
Insulin injections
Insulin injections is a Insulin Small molecule drug developed by University of Campania Luigi Vanvitelli. It is currently FDA-approved. Also known as: MDI.
Insulin injections are used to treat conditions such as Diabetes Mellitus and Type 2 Diabetes Mellitus, as they work by binding to the insulin receptor, a protein, to act as an agonist and stimulate the body's response to insulin. Insulin injections, such as Lantus (insulin glargine [rDNA origin] injection), are administered to help regulate blood sugar levels in individuals with these conditions.
At a glance
| Generic name | Insulin injections |
|---|---|
| Also known as | MDI |
| Sponsor | University of Campania Luigi Vanvitelli |
| Drug class | Insulin |
| Target | Insulin receptor |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Pipeline indications
Common side effects
Drug interactions
- Beta-blockers
- ACE inhibitors
Key clinical trials
- Text Message for Adolescents With Poorly Controlled Type 1 Diabetes (NA)
- Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes (NA)
- ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly (PHASE2)
- IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion (NA)
- Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (PHASE2)
- Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes (NA)
- Exenatide for Smoking Cessation and Prevention of Weight Gain (PHASE2)
- Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Insulin injections CI brief — competitive landscape report
- Insulin injections updates RSS · CI watch RSS
- University of Campania Luigi Vanvitelli portfolio CI
Frequently asked questions about Insulin injections
What is Insulin injections?
Who makes Insulin injections?
Is Insulin injections also known as anything else?
What drug class is Insulin injections in?
What development phase is Insulin injections in?
What does Insulin injections target?
Related
- Drug class: All Insulin drugs
- Target: All drugs targeting Insulin receptor
- Manufacturer: University of Campania Luigi Vanvitelli — full pipeline
- Therapeutic area: All drugs in Metabolic
- Also known as: MDI
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing